JAZZ — Jazz Pharmaceuticals plc
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on JAZZ
| date | signal | measured base rate |
|---|---|---|
| 2026-08-12 | Fair value gap, bearish structure | -0.45% over 21 days · t = -3.29 · n = 108,591 statistically distinguishable from its control group |
| 2026-08-05 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-04 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-09 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-01 | Cluster sale: three or more insiders insider | -0.37% over 21 days · t = -3.38 · n = 21,542 statistically distinguishable from its control group |
| 2026-05-22 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-05 | Pearce Samantha EVP, Chief Commercial Officer | Shares withheld for tax | 780 | 261.62 | 204.1K |
| 2026-08-05 | ENRIGHT PATRICK G Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | Mulligan Seamus Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | RIEDEL NORBERT G Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | LOVE TED W Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | Winningham Rick E Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | Hamill Laura Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | McSharry Heather Ann Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | Smith Mark Douglas Director | Grant or award | 1.6K | 0.00 | 0 |
| 2026-08-05 | Cook Jennifer E. Director | Grant or award | 1.6K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| BlackRock, Inc. | 1.1B | 5.6M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 564.0M | 3.0M |
| Capital World Investors | 505.4M | 2.7M |
| VANGUARD CAPITAL MANAGEMENT LLC | 500.7M | 2.6M |
| FMR LLC | 430.2M | 2.3M |
| FRANKLIN RESOURCES INC | 370.3M | 2.0M |
| DIMENSIONAL FUND ADVISORS LP | 358.3M | 1.9M |
| STATE STREET CORP | 357.6M | 1.9M |
| EcoR1 Capital, LLC | 322.6M | 1.7M |
| Bank of New York Mellon Corp | 317.5M | 1.7M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-10 | 2026-08-10 | on EDGAR ↗ |
| 8-K | 2026-08-10 | 2026-08-10 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-05 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-05 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-05 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-05 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-05 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-05 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Jazz Pharmaceuticals Plc (JAZZ) filed form 8-K · 2026-08-10 · SEC EDGAR
Ask the AI about JAZZ
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →